PLGLA polyclonal (N-term), anti-human
€0.00
In stock
SKU
AC-AP19025a
Catalog Number: AC-AP19025a
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB39622
Applications: WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB39622
Applications: WB
Datasheet
Request Information
Background:
PLGLA may bind non-covalently to lysine binding sites present in the kringle structures of plasminogen. This may interfere with the binding of fibrin or alpha-2-antiplasmin to plasminogen and may result in the localization of activity at sites necessary for extracellular matrix destruction (By similarity).
Other Names:
Plasminogen-like protein A, Plasminogen-like protein A1, Plasminogen-related protein A, PLGLA, PLGLA1, PLGP2, PRGA
Target/Specificity:
This PLGLA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 23-48 amino acids from the N-terminal region of human PLGLA.
Antigen Region:
23-48
Antigen Type: Synthetic Peptide
Gene Name: PLGLA
Primary Accession: Q15195
Other Accession: Q02325
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
PLGLA may bind non-covalently to lysine binding sites present in the kringle structures of plasminogen. This may interfere with the binding of fibrin or alpha-2-antiplasmin to plasminogen and may result in the localization of activity at sites necessary for extracellular matrix destruction (By similarity).
Other Names:
Plasminogen-like protein A, Plasminogen-like protein A1, Plasminogen-related protein A, PLGLA, PLGLA1, PLGP2, PRGA
Target/Specificity:
This PLGLA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 23-48 amino acids from the N-terminal region of human PLGLA.
Antigen Region:
23-48
Antigen Type: Synthetic Peptide
Gene Name: PLGLA
Primary Accession: Q15195
Other Accession: Q02325
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review